ロード中...
Nivolumab in combination with ipilimumab for the treatment of melanoma
Melanoma patients develop resistance to most therapies, including chemo- and targeted-therapy drugs. Single-agent therapies are ineffective due to the heterogeneous nature of tumors comprising several subpopulations. Treatment of melanoma with immune-based therapies such as anti-cytotoxic T-lymphocy...
保存先:
| 出版年: | Expert Rev Anticancer Ther |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4669949/ https://ncbi.nlm.nih.gov/pubmed/26402246 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14737140.2015.1093418 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|